Sumitomo Mitsui Trust Holdings, Inc. Rubius Therapeutics, Inc. Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 27, 2020	SELL	$3.74 - $9.84 $5.37 Million - $14.1 Million	-1,436,013 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$7.23 - $14.12 $150,593 - $294,105	-20,829 Reduced 1.43%	1,436,013 $13.6 Million
Q3 2019 Oct 31, 2019	BUY	$7.85 - $15.75 $1.69 Million - $3.39 Million	215,543 Added 17.36%	1,456,842 $11.4 Million
Q2 2019 Jul 29, 2019	BUY	$13.5 - $19.94 $9.98 Million - $14.7 Million	739,449 Added 147.34%	1,241,299 $19.5 Million
Q1 2019 May 08, 2019	BUY	$13.27 - $18.51 $6.66 Million - $9.29 Million	501,850 New	501,850 $9.08 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.